Dreem provides effective sleep care to individuals as well as healthcare providers for their patients. Its mission is to address one of the world’s largest unmet needs, sleep, and to become the global leader in screening, diagnosing and treating sleep disorders. Since Dreem’s founding in 2014, it has raised $60 million from investors including Johnson & Johnson and put together a team of 90, split across in New York, Paris and Taipei. Along the way, it has created a scientific advisory board of four leading sleep doctors and neuroscientists.